PHOSPHATIDYLGLYCEROL IS A PHYSIOLOGICAL ACTIVATOR OF NUCLEAR-PROTEIN KINASE-C

Citation
Nr. Murray et Ap. Fields, PHOSPHATIDYLGLYCEROL IS A PHYSIOLOGICAL ACTIVATOR OF NUCLEAR-PROTEIN KINASE-C, The Journal of biological chemistry, 273(19), 1998, pp. 11514-11520
Citations number
30
Categorie Soggetti
Biology
ISSN journal
00219258
Volume
273
Issue
19
Year of publication
1998
Pages
11514 - 11520
Database
ISI
SICI code
0021-9258(1998)273:19<11514:PIAPAO>2.0.ZU;2-J
Abstract
A major mechanism by which protein kinase C (PKC) function is regulate d is through the selective targeting and activation of individual PKC isotypes at distinct subcellular locations. PHC beta(II), is selective ly activated at the nucleus during G(2), phase of cell cycle where it is required for entry into mitosis. Selective nuclear activation of PK C beta(II), is conferred by molecular determinants within the carboxyl -terminal catalytic domain of the kinase (Walker, S. D., Murray, N. R. , Burns, D. J., and Fields, A. P. (1995) Proc. Natl. Acad. Sci. U.S.A. 92, 9156-9160). We previously described a lipid-like PRC activator in nuclear membranes, termed nuclear membrane activation factor (NMAF), that potently stimulates PRC beta(II), activity through interactions i nvolving this domain (Murray, N. R., Burns, D. J., and Fields, AP. (19 94) J. Biol. Chem. 269, 21385-21390). We have now identified NMAF as p hosphatidylglycerol (PG), based on several lines of evidence. First, N MAF cofractionates with PG as a single peak of activity through multip le chromatographic separations and exhibits phospholipase sensitivity identical to that of PG. Second, purified PG, but not other phospholip ids, exhibits dose-dependent NMAF activity. Third, defined molecular s pecies of PG exhibit different abilities to stimulate PKC beta(II), ac tivity. 1,2-Dioleoyl-PG possesses significantly higher activity than o ther PG species, suggesting that both fatty acid side chain compositio n and the glycerol head group are important determinants for activity. Fourth, in vitro binding studies demonstrate that PG binds to the car boxyl-terminal region of PKC beta(II),, the same region we previously implicated in NMAF-mediated activation of PKC beta(II),. Taken togethe r, our results indicate that specific molecular species of nuclear PG function to physiologically regulate PKC beta(II), activity at the nuc leus.